US Health and Human Services Secretary Sylvia M. Burwell announces new progams and financial incentives to help accountable care organizations (ACOs) and professional medical associations make the transition from fee-for-service to value-based healthcare delivery.
If healthcare providers need another reason to move from fee-for-service delivery models to those based on patients’ health outcomes, the US Department of Health and Human Services (HHS) just provided one: an $840 million initiative, most of it grants, to help fund the cost of making the transition.
HHS Secretary Sylvia M. Burwell yesterday unveiled a program that will allow successful applicants to receive federal dollars to help them “rethink and redesign their practices,” while moving toward delivery models based on coordinated care and improving population health, according to a department statement.
The plan seems tailor-made to boost efforts by accountable care organizations (ACOs), which were created by the 2010 Patient Protection and Affordable Care Act (ACA) to allow entities of hospitals, practice groups, health plans, and other medical providers work together to improve health and patient satisfaction — and find savings – across a population. ACOs that make the grade, based on quality measures from the Centers for Medicare and Medicaid (CMS), are eligible for higher reimbursements from Medicare.
Giving ACOs the opportunity to learn from each other as they make this transition is a chief initiative of The American Journal of Managed Care, which recently brought a multistakeholder group of healthcare leaders together for its ACO and Emerging Healthcare Delivery Coalition meeting in Miami.
The HHS announcement said the program hopes to reach 150,000 healthcare providers through the Transforming Clinical Practice Initiative, which will take aim at things like unnecessary tests and repeated hospitalizations.
To date, CMS has encouraged a transition from volume- to value-based care through 2 programs: the Pioneer ACOs, large systems that already had some experience with value-based delivery, and the Medicare Shared Savings Program, which has enrolled hundreds of ACOs of varying size and composition. So far, however, the Pioneers program has had mixed success; a paper just published this week by the Journal of the American Medical Association outlined the challenges of the early years of the program, which launched in 2011. Since 2012, the Pioneers program has shrunk from 32 to 19 participants.
According to the HHS announcement, strategies that the new program hopes to promote include:
“The administration is partnering with clinicians to find better ways to deliver care, pay providers and distribute information to improve the quality of care we receive and spend our nation’s dollars more wisely,” Burwell said. “We all have a stake in achieving these goals and delivering for patients, providers and taxpayers alike.”
Another part of the initiative will be Support and Alignment Networks. CMS will award “cooperative agreements” to professional associations that educate members in value-based practices, through continuing medical education credits and other means.
Around the Web
Review Emphasizes Potential Infection Risks With BTK Inhibitors
November 2nd 2024Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, patients have significantly increased risks of infection, especially in the upper respiratory tract.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
PAH Treatment Outcomes Similar Regardless of Diagnosis Time
November 1st 2024The study findings underscore the importance of early initiation of macitentan and tadalafil among patients who have pulmonary arterial hypertension (PAH), and represent a shift in understanding of prognosis based on diagnosis timing.
Read More